Dr Reddys Laboratories (RDY) Consolidated Net Income (2009 - 2026)

Dr Reddys Laboratories has reported Consolidated Net Income for 18 years, with the latest figure at $45.9 million in Q2 2026.

• On a quarterly basis, Consolidated Net Income fell 72.12% year-over-year to $45.9 million in Q2 2026; TTM through Jun 2026 was -$1.4 billion, a 312.39% decrease from a year earlier, with the FY2026 full-year figure at $481.1 million, up 102.22% from the prior year.
• Consolidated Net Income was $45.9 million for Q2 2026 at Dr Reddys Laboratories, down from $258.8 million in the prior quarter.
• The five-year high for Consolidated Net Income was $258.8 million in Q1 2026, with the low at -$1.9 billion in Q4 2025.
• Average Consolidated Net Income over 5 years is $38.0 million, with a median of $164.1 million recorded in 2025.
• The sharpest annual moves came in 2023 and 2025: Consolidated Net Income soared 1352.3% in 2023, then slumped 1243.22% in 2025.
• Over 5 years, Consolidated Net Income stood at $117.0 million in 2022, then surged by 41.54% to $165.6 million in 2023, then gained by 0.4% to $166.3 million in 2024, then plunged by 1243.22% to -$1.9 billion in 2025, then soared by 102.42% to $45.9 million in 2026.
• The last three Consolidated Net Income figures came in at $45.9 million (Q2 2026), $258.8 million (Q1 2026), and -$1.9 billion (Q4 2025), per Business Quant data.